HER2 testing and correlation with efficacy of trastuzumab therapy

Oncology (Williston Park). 2002 Nov;16(11):1576, 1578.
No abstract available

Publication types

  • Comment
  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / therapeutic use
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / genetics*
  • Female
  • Genetic Testing / methods*
  • Humans
  • Immunohistochemistry
  • In Situ Hybridization, Fluorescence*
  • Patient Selection
  • Receptor, ErbB-2 / genetics*
  • Sensitivity and Specificity
  • Trastuzumab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Receptor, ErbB-2
  • Trastuzumab